Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 19, 2020 10:24am
111 Views
Post# 31930240

RE:RE:Interesting and hell of a discovery

RE:RE:Interesting and hell of a discovery Makes no sense to see the selling, eps. today where Scotia continues to sell, including a cross(?) of 57.5K at .65.  At least selling is by one firm (shareholder?).

On the "eve" of earnings and an update on activities, it makes no sense to me. Company is so tight lipped, the selling cannot be broadcasting any negative coroporate developments.  At most I would say an investor who bought in for the COVID play is selling based on the recent success with vaccines.

Debt free, growing base business, great pipleline, but needing commerialization of PGX with a signed deal...the positives outweigh the negatives and the reward / risk is still highly favourable
<< Previous
Bullboard Posts
Next >>